Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02293655 · ClinicalTrials.gov registry record · Phase 4
The Effects of ADHD Medication (TEAM) Study
A Phase 4 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 204
- Enrollment target
NCT02293655 is a Phase 4 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 204 participants.
The verdict
NCT02293655, a Phase 4 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 204 participants
- Enrollment target
Study Summary
This study evaluates the effects of receiving and then discontinuing methylphenidate (MPH) in children with ADHD. After receiving MPH for 8 weeks, participants will be randomized to either discontinue MPH (and receive placebo) OR remain on MPH for 4 weeks.
Interventions
- DRUG OROS-Methylphenidate (MPH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2015-01-12 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02293655
The ClinicalTrials.gov registry entry for NCT02293655 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OROS-Methylphenidate (MPH) is the first listed.
NCT02293655 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02293655 about?
NCT02293655 is a clinical study titled "The Effects of ADHD Medication (TEAM) Study". This study evaluates the effects of receiving and then discontinuing methylphenidate (MPH) in children with ADHD. After receiving MPH for 8 weeks, participants will be randomized to either discontinue MPH (and receive placebo) OR remain on MPH for 4 weeks.
What is the current status of trial NCT02293655?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 204 participants. The study started on 2015-01-12. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT02293655?
The interventions under investigation include: OROS-Methylphenidate (MPH) (DRUG).
Who is sponsoring clinical trial NCT02293655?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.